Aimmune Therapeutics

About:

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

Website: http://www.aimmune.com

Twitter/X: aimmune

Top Investors: RA Capital Management, Fidelity, Foresite Capital, Longitude Capital, Adage Capital Management

Description:

Aimmune Therapeutics is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.